Artery procedure to treat type 2 diabetes and related problems
Part of Heart & circulation, Hormones & metabolism clinical trials.
This Phase 1 study tests a new artery “ablation” procedure for people with type 2 diabetes, aiming to improve diabetes and related conditions like high blood pressure. It will also check whether the procedure is safe and works well enough to study further.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Age 21 to 65 when you enroll
- Type 2 diabetes with specific lab levels: fasting glucose, HbA1c, triglycerides, and diabetes duration (10 years or less)
- You must be on metformin by mouth (additional diabetes pills are allowed)
- Body weight: BMI between 27.5 and 40
- Have workable kidney or liver artery anatomy for the procedure (specific vessel size and length)
- You likely cannot have insulin use, HbA1c above 9.0%, major recent low/high sugar emergencies, or certain significant eye/nerve complications
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This Phase 1 study tests whether a minimally invasive artery procedure can improve type 2 diabetes and related health problems by targeting kidney and liver blood vessels. Because it’s early-stage, the main goal is safety and learning how the treatment works in people who meet specific diabetes, blood pressure, and blood test requirements.
This trial tests a procedure called renal denervation to lower blood pressure in people whose medication isn't enough. It uses a special catheter to calm nerves near the kidneys that may be overactive.
This trial tests a procedure that targets nerves near the kidney (renal denervation) to help lower blood pressure in people whose hypertension is not controlled despite medication. It uses a special 3D mapping system to guide the procedure.
This study tests a new combination of three medications (THP-00101, THP-00102, and THP-00103) for people with type 2 diabetes and essential high blood pressure. It aims to see if this combination is safe and effective compared to standard treatments.
This trial tests a procedure called renal denervation, which uses targeted energy to calm overactive kidney nerves that can raise blood pressure. It is for people with high diastolic blood pressure (the bottom number) who have not yet taken blood pressure medication.
This trial tests a new way to perform a procedure called renal denervation, which uses radio waves to calm overactive kidney nerves that can raise blood pressure. By getting feedback during the procedure, doctors hope to make the treatment more effective for people with high blood pressure.
Hear when a new High blood pressure trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.